Brief: Genocea To Present Long-Term Follow-Up Data From Gen-009 Neoantigen Vaccine At Virtual Asco 2020
13/05/2020 23:11
May 13 (Reuters) - Genocea Biosciences Inc GNCA.O :
* GENOCEA TO PRESENT LONG-TERM FOLLOW-UP DATA FROM GEN-009
NEOANTIGEN VACCINE AT VIRTUAL ASCO 2020
* GENOCEA BIOSCIENCES INC - SEVEN OUT OF EIGHT PATIENTS
TREATED ON
PART A OF STUDY ARE WITHOUT DISEASE PROGRESSION AT ONE-YEAR
MEDIAN FOLLOW-UP
Source text for Eikon: ID:nGNX7hwPyn
Further company coverage: GNCA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genocea Biosciences
See all newsBluebird, Chimerix, Clovis have under 6 months of cash left - Truist
Genocea Biosciences plunges as it winds down operations
Brief: Genocea Announces Wind Down Of Operations And Delisting From Nasdaq
Genocea Biosciences Inc reports results for the quarter ended in March - Earnings Summary
U.S. STOCKS ON THE MOVE-Oppenheimer Holdings, IES Holdings Inc, Avantor Inc